ArticleHuman molecular genetics2026
Limited penetrance of dominantly inherited AIRE variants in a population-based cohort.
Article in Human molecular genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Pathogenic variants in the autoimmune regulator gene (AIRE) cause Autoimmune polyendocrine syndrome type 1 (APS-1). The majority of disease-causing variants are inherited recessively, while several heterozygous AIRE variants have been reported in the literature as having dominant-negative or partially inhibitory effects. Additionally, some heterozygous AIRE variants have been implicated in milder and more common autoimmune phenotypes in disease cohort studies. The contribution of these variants to disease risk in unselected populations has not been assessed at scale. We aimed to investigate the prevalence and phenotypic impact of rare coding variants in AIRE in 449 075 participants from the UK Biobank (UKB). A literature review identified 25 rare heterozygous AIRE variants previously reported in association with autoimmunity, including variants described as dominant-negative or partially inhibitory, 13 of which were observed in UKB, collectively carried by 2123 participants. Filtering and annotation of rare coding AIRE variants identified a further 180 rare coding AIRE variants in 1934 UKB participants. Phenotype association analysis revealed no significant associations between rare heterozygous AIRE variants previously reported in association with autoimmunity and APS-1-associated traits after multiple-testing correction. Similarly, no statistically significant associations were observed for other heterozygous carriers of missense variants, frameshift/protein-truncating variants, or domain-specific groupings. These findings are consistent with a predominantly recessive model of AIRE-associated disease and indicate limited penetrance of rare heterozygous variants in the UKB population. Our work highlights the need for cautious interpretation of heterozygous AIRE variants in clinical settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.